RT Journal Article
T1 Advanced Glycation End Products and Their Involvement in Cardiovascular Disease.
A1 Yubero-Serrano, Elena M
A1 Perez-Martinez, Pablo
K1 Advanced glycation end products
K1 Cardiovascular diseases
K1 Diet
AB Circulating levels and tissue accumulation of advanced glyca-tion end products (AGEs) are strongly linked with metabolicimbalance and the progression of chronic diseases, includingcardiovascular disease (CVD). 1,2 Diet is the most importantexogenous source of AGEs contributing to the total body AGEsload. Experimental and clinical evidence suggests that thereduction in body AGE content, by dietary AGE restriction,could modulate different pathways involved in the pathophy-siology of CVD
PB Sage Publications
YR 2020
FD 2020-04-03
LK http://hdl.handle.net/10668/15315
UL http://hdl.handle.net/10668/15315
LA en
NO Yubero-Serrano EM, Pérez-Martínez P. Advanced Glycation End Products and Their Involvement in Cardiovascular Disease. Angiology. 2020 Sep;71(8):698-700
DS RISalud
RD Apr 9, 2025